4//SEC Filing
Graham G. Walmsley 4
Accession 0000950170-25-046271
CIK 0001744659other
Filed
Mar 26, 8:00 PM ET
Accepted
Mar 27, 7:42 PM ET
Size
8.9 KB
Accession
0000950170-25-046271
Insider Transaction Report
Form 4
Graham G. Walmsley
Director
Transactions
- Purchase
Common Stock
2025-03-27$43.55/sh+50,000$2,177,700→ 1,200,000 total(indirect: See Footnote 1) - Purchase
Common Stock
2025-03-25$44.75/sh+91,309$4,085,804→ 1,091,309 total(indirect: See Footnote 1) - Purchase
Common Stock
2025-03-26$43.01/sh+58,691$2,524,417→ 1,150,000 total(indirect: See Footnote 1)
Holdings
- 2,168
Common Stock
Footnotes (1)
- [F1]The shares are held by Logos Global Master Fund LP ("Logos Master Fund") and Logos Opportunities Fund IV LP ("LOF IV"). Logos GP LLC ("Logos GP") is the general partner of Logos Master Fund and the Reporting Person is a managing member of Logos GP. Logos Opportunities IV GP LLC ("GP IV") is the general partner of LOF IV and the Reporting Person is a managing member of GP IV. The Reporting Person disclaims beneficial ownership of the securities except to the extent of his pecuniary interest therein.
Documents
Issuer
Akero Therapeutics, Inc.
CIK 0001744659
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001777517
Filing Metadata
- Form type
- 4
- Filed
- Mar 26, 8:00 PM ET
- Accepted
- Mar 27, 7:42 PM ET
- Size
- 8.9 KB